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years old. There are alternations in the maximum values for
gender in the 0 to 20 years old band. CONCLUSIONS: This
study reﬂects the need to determine an optimum number of
bands; that is, to add the information in some speciﬁc intervals
that allow us to carry out an efﬁcient analysis without losing the
necessary perspective in order to obtain related conclusions with
the aim of the study. It proves that a previous analysis is essen-
tial to evaluate the behaviour of the cost per inhabitant of a
PHCT.
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OBJECTIVES: To organize and classify existing Canadian health
information databases into a searchable repository that will
assist in identifying and assessing Canadian data available for
health outcomes and related research. METHODS: The identi-
ﬁcation of Canadian health information databases began with a
structured search strategy involving Medline (PubMed, OVID);
Internet search engines; web sites of a number of organizations,
universities and government bodies; and personal communica-
tions. Canadian databases with data from the year 2000 and
onwards were included. Databases were assigned to one of four
basic types (Administrative, Registry, Surveillance and Survey)
and further classiﬁed in a hierarchical structure using categories,
sub-categories and low-level terms. The three high-level cate-
gories were Medical Condition (MC), Population Health (PH)
and Health Services Utilization (HSU). Approximately 20% of
the identiﬁed databases were further proﬁled in detail, with
recording of information on an additional 20 variable ﬁelds
including sample size, data collection methods and data quality.
RESULTS: The creation of a classiﬁcation structure fully char-
acterized the breadth and scope of the 255 unique databases 
initially identiﬁed. By database type, the largest proportion of
databases was classiﬁed as survey (34%; n = 87), followed by
administrative (28%; n = 72), registry (22%; n = 56) and ﬁnally
surveillance (16%; n = 40). By non-exclusive database category,
most were classiﬁed as PH (n = 140), followed by HSU (n = 116)
and ﬁnally MC (n = 114). Canadian health databases were found
to provide information across a wide range of clinical conditions,
particularly those related to high disease burden areas. In addi-
tion, they provided health utilization and determinant data.
Some data gaps were recognized, such as environmental expo-
sure data, data identifying speciﬁc subpopulations, and infor-
mation needed to fully assess data quality. CONCLUSIONS:
Classifying existing Canadian health information databases
within a single, organized register is expected to provide an effec-
tive research tool in the planning of health outcomes and related
research.
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OBJECTIVES: Parameters of central tendency (mean) are often
estimated in budget impact assessment (BIA) with less emphasis
on parameters of spread (variance); critical to ﬁxed funding (FF)
policies (e.g. envelope systems) is accuracy of the estimate and
maximal precision. The complexity and diversity of the hospital
pathology mix and its treatment are the main theoretical hurdles
encountered. In this analysis, the variance of the drug treatment
reimbursement cost was investigated on the Main Diagnostic
Code (MDC) and the All Patients Reﬁned Diagnosis Related
Groups (APRDRG)-level. The aim was to select low cost 
variance diagnoses which would enhance precision in FF.
METHODS: Belgian hospitals register admission data in
minimum basic data sets (MBDS): we extracted anonymous data
from stays of 21 peripheral Flemish hospitals (during 2002).
MBDS contains ICD-9-CM codes, performed procedures, stay
parameters (e.g. risk of mortality), patient characteristics (age,
gender) and drug utilization data with the national insurance
cost. Data were analyzed in SPSSWIN® 12.0. RESULTS: The
database contained 368,618 unique stays. On MDC-level, the ﬁt
between mean cost and variance was merely a non-linear rela-
tionship; the MDC’s cardio-vascular (CV) disease, myelopro-
liferation & neoplasms, infectious disease and liver disease
exhibited a linear relationship with r2 > 0.90; in these MDC’s
low mean cost pathologies also allow ﬁxed funding. On
APRDRG-level, increased cost variance probably reﬂects
increased drug utilisation variability and/or heterogenicity in
drug pricing. llustrative examples: the ratio of mean cost for
cesarean (95€) to vaginal (27€) delivery is about 4 but the ratio
of variances exceeds 10. In the CV area, the corresponding ratios
for heart failure (269€) to angina (104€) are respectively 2.5 and
8. CONCLUSIONS: Reducing mean cost is important to BIA
but to FF reducing cost variance is essential in order for the
funding to be in line with the resources used.
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OBJECTIVES: The Medicare Prescription Drug, Improvement
and Modernization Act (MMA) of 2003 requires the General
Accounting Ofﬁce (GAO) to conduct surveys in 2004 and 2005
to determine the hospital acquisition cost for speciﬁed outpatient
drugs. The Centers for Medicare and Medicaid Services (CMS)
will use the survey data to set hospital outpatient drug payment
rates for 2006. This study explores the potential impact of poor
study design on 2006 hospital outpatient prospective payment
system (OPPS) drug payments. METHODS: Various methods of
recording acquisition cost were collected from hospital systems
and categorized. Past CMS and GAO discussions of acquisition
cost were identiﬁed and accumulated in an indexed database.
Findings from the hospital sources and the governmental sources
were compared and underlying assumptions examined with a
view toward predicting the GAO approach to determining hos-
pital drug acquisition cost. RESULTS: The hospital survey
revealed signiﬁcant variation in how acquisition cost is deﬁned
and recorded in hospital pharmacies. The most common method
reported was a percentage of average wholesale price (AWP). The
next most common method reported was actual acquisition cost
at a certain point in time, updated quarterly. Constantly updated
acquisition cost was rare, due to the required information tech-
nology. When entries in the indexed database of CMS and GAO
discussions of acquisition cost were compared to the hospital
